Eden Research plc

October 12, 2009 07:36 ET

Result of AGM

                                             EDEN RESEARCH PLC
                                               AGM STATEMENT

Eden  Research  plc,  a leading UK agrochemical development company, announces that at its  Annual  General
Meeting held today all resolutions contained in the notice of meeting were duly passed.
At the meeting, Sir Ben Gill, Non-executive Chairman, made the following statement:
"Recent changes in European Union legislation have meant that there is to be a significant reduction in the
portfolio  of  available  agrochemicals to control pests and diseases at a time when  there  is  increasing
concern  about  the  future of our food supplies and the need to increase global  production  to  meet  the
burgeoning demands for food and for crops being used for energy production.
The  European Union legislation changes will also favour and encourage the development of "green"  products
which  strikes to the heart of the research and development work that Eden is involved in. As a result  the
interest in our products continues to be substantial and we look forward to successful exploitation of  the
substantial number of options open to us.
Our  East African partners, Lachlan Kenya Limited, are now compiling and will submit a registration dossier
for  3AEY  based  on  the  Eden EU dossier. This will gain access for Eden's lead  product  and  subsequent
products into the valuable Kenyan cut flower, fruit and vegetable markets.
Environmental  Solutions  (North  Africa)  have been appointed  as  a  distribution  partner  to  Eden  and
registration documents for 3AEY have been compiled for submission into key countries such as Algeria.  This
submission  will also help support further Eden products in other country and crop markets in this  region.
Recent  excellent trial results on other crops in Egypt show the significant potential in the  Middle  East
and Eden is now in negotiations to expand the licences there.
Both  Cheminova  and  Redestos  are  continuing their work to collate the  necessary  information  for  the
submission of the dossiers required for national approvals for 3AEY, which will ultimately lead to sales of
product throughout Europe and the rest of the World.
Following  consultation with the UK regulatory authority, CRD (previously PSD), on the  3AEY  EU  dossiers,
several  minor  points  raised  have  been  satisfactorily addressed  by  our  regulatory  consultants  JSC
International and the final dossier has been submitted to CRD.
To  further  extend our IP value and product portfolio, formulation work has been on-going and a  range  of
terpene  combinations have been encapsulated for large scale screening against key pests in new areas  such
as grain storage pests and household/personal care treatments.
We  are  currently in discussion with various parties for the licensing of our nematode and other  products
and,  as  such, hope to announce details of those potential agreements in due course together with news  on
the  several  co-encapsulation  positions where there has been major interest  in  utilising  our  platform
technology to enhance efficacy and generate new intellectual property positions for our partners.
These  deals  should  enable the business to expedite the commercialisation of  its  product  pipeline  and
maximise  the value of the Company's intellectual property. The further proof of the technology  will  also
pave the way for a smooth transition to a more senior market next year."
Sir Ben Gill, Non-executive Chairman
For further information please contact:

Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844
Matthew Robinson, FinnCap
T: 020 7600 1658

Contact Information

  • Eden Research plc